Suk Lee

Principal Scientist at Asieris Pharmaceuticals

Suk Lee is a highly experienced scientist specializing in Antibody-Drug Conjugates (ADCs) and immuno-oncology. They have a strong background in drug target identification, in vitro/ex vivo target validations, and patient-derived organoid models of bladder and prostate cancer. Suk Lee has held positions at prestigious institutions such as Stanford University, Columbia University Irving Medical Center, and currently works as a Principal Scientist at Asieris Pharmaceuticals.

Links

Previous companies

23andMe logo
Gilead Sciences logo

Timeline

  • Principal Scientist

    March 1, 2024 - present

  • Senior Scientist III

    August, 2022